10-Hydroxy-1-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)decan-1-one, 95.0%, 1g

2-Benzyl-2h-1,2,3,4-tetrazol-5-amine, 95%, 250mg

2-Cyanopropanoic acid, 97.0%, 250mg

(S)-5-Oxopyrrolidine-2-carboxamide, 95.0%, 1g

Ethyl 2-(1,1-dioxidothiomorpholino)acetate, 98%, 1g

4'-(2,5-Difluorophenoxy)acetophenone, 97.0%, 100g

5,7-Dichloro-1-methyl-1H-indole-2,3-dione, 95.0%, 500mg

2-Bromo-6-iodoaniline, 95.0%, 25g

1,3-Dibromo-5-iodobenzene>98.0%(GC)1g

1,1'-(((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(2-hydroxy-6,1-phenylene))diethanone, 95.0%, 250mg

2-(2-Methoxyethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

transcinamaldehído, mín. 98,5 %, para síntesis, 250 ml, envase de vidrio

n-(4-Hydroxyphenyl)-2-methoxyacetamide, 97%, 100mg